Use of Insulin Glargine to Treat Diabetic Ketoacidosis

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2012

Conditions
Diabetic Ketoacidosis
Interventions
DRUG

glargine

0.3u/kg of glargine, subcutaneously, once

DRUG

saline

0.3u/kg of saline, subcutaneously, once

Trial Locations (1)

37232

Vanderbilt University Monroe Carell Children's Hospital, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00179127 - Use of Insulin Glargine to Treat Diabetic Ketoacidosis | Biotech Hunter | Biotech Hunter